Arcaroli JJ, Touban BM, Tan AC et al.
University of Colorado, Denver, CO, USA.
Clin Cancer Res 2010;16:4165–77.
Editor’s note: In the current study, the authors investigated the efficacy of saracatinib, a Src kinase inhibitor, in colorectal cancer (CRC). They tested a new human CRC explant model; 10 resected tumors from patients with CRC were explanted directly from surgery into mice. The authors consider this to be a better reflection of human malignancy than known xenograft models.